Forgot Password

Thank you for your request!

We will soon reach out to you.

Thank you for downloading..!

Contact us for more information.
Home » Healthcare » Medical Devices » HME-1371015

  • Global Biochips Markets Insights, Opportunity, Analysis, Market Shares And Forecast 2017 – 2023

  • Publish: March 2016 | Report Code: HME-1371015

* For discount/customization and buying a particular chapter click here or write to us at [email protected]

The global biochips market is anticipated to grow at a CAGR of 18.4 % during2016 to 2022. The market has generated the revenue $7.63 Billion in 2016 and is anticipated to reach up to $ 17.65 Billion by 2022. The major driving forces for the market of biochips are rise in diagnosis & treatment of cancer, Increase Government funding, Growth in personalized medicine and Technical advances. R&D is considered one of the major factors for the growth of the market since it leads to the discovery of new and technologically advanced products.

 Due to the increase in number of chronic cases such as asthma and multiple sclerosis and diseases like cancer and diabetes increased the demand of diagnosis globally which increased the market of biochip worldwide. According to world health organization in 2015 it has seen that in U.S. more than 1658370 new cancer cases had come in which more than 848200 male cancer cases are there and 810170 female cancer cases. It has also seen that more than 589430 death has caused due to cancer in which more than 312150 are male and 277280 are female. In India it has seen that in 2015 more than 666,563 death has caused due to cancer in which 305,000 are females and 361,474 are male Due to increasing chronic cases and deaths it increased the demand of medical checkup which ultimately increased the market of biochip.   The increasing aging population worldwide also become the major factor which increase the market of biochip globally. It has seen that in Germany only 13 percent population are 14 year old or above more than 21 percent of total Germany population aging 65 and above. In UK only 17.6 percent population are having age 14 or above, 65 percent population are from 15 to 65 and 17.5 percent population are aging 65 or above. Due to increasing aging population worldwide it increased the demand of diagnosis which accelerated the market of biochip. The food allergies and eczema are the most common chronic non-communicable diseases in children in various numbers of countries worldwide. It is seen that more than 8% population are suffering from food allergy, globally in which approximately 6% aged 0-2 years have a food allergy

Some of the factors acting as the restraint for the market are less accuracy of biochips it may lead to wrong analysis, low rate of translation of discoveries in drugs, protein biomarkers and medical devices low acceptance due to high cost and availability of alternative technologies are restraining the growth of biochips market. Also the lack of technically skilled professionals hinders the growth of the market.

The global biochips market is segmented on the basis of applications and types. On the basis of applications the market of biochipste is segmented into lab-on-chip (LOC) market, DNA micro array market and protein micro array. Based on types the global biochips market is segmented into protein microarray market and other array market DNA microarrays represent the largest segment of biochips market and will be the largest contributor during the forecasted period, this segment will be followed by lab-on-chip in due to its wide applications and increased adoption by various biotechnology, pharmaceutical companies, and research laboratories and the protein microarrays will be the third largest due to advances in the fields of proteomics and genomics.

Geographically the global biochip market is segmented into North America, Europe, Asia-Pacific and Rest of World. North America dominates the global biochips market owing to large number of aging population,broad technical applications of biochips and early technology adopter culture  followed by Europe and Asia-Pacific. Asia-Pacific market will drive the growth of the market in future owing to growing economies like India and China. India and china are the major companies which helps to drive the market of Asia pacific biochip market. 

Some of the major players of the market are Thermofisher, Agilent technologies Inc, Biochain institute Inc, Biomérieux sa, Bio-rad laboratories Inc, Caliper life sciences in, Cepheid In, Cybrdi Inc. Emd Millipore, Fluidigm corp, Gamida for life group, Illumina Inc, Imgenex, Life technologies corp, Origene technologies Inc. Acquisition, merger, innovation and new product launch are the major technologies which helps to sustain in the market.

In 2016,thermofisher  a US based company has announced that they had completed the acquisition of Affymetrix Inc, a US based company that provides cellular and genetic analytics products.Similarly in 2016, Agilent Technologies Inc. has announced that they had completed the acquisition of iLab Solutions, LLC a market leader of cloud based solutions specially for core laboratory management.

1. INTRODUCTION
1.1. EXECUTIVE SUMMARY
1.2. MARKET SCOPE
 
2. MARKET OVERVIEW
2.1. GLOBAL BIOCHIPS MARKET: EVOLUTION & TRANSITION
2.2. MARKET DEFINITION & SCOPE
2.3. INDUSTRY STRUCTURE
2.4. REGULATORY FRAMEWORK 
2.5. TOTAL MARKET ANALYSIS
2.5.1. TOP 5 FINDINGS
2.5.2. TOP 5 OPPORTUNITY MARKETS
2.5.3. TOP 5 COMPANIES
2.5.4. TOP 3 COMPETITIVE STRATEGIES
2.6. ESTIMATION ANALYSIS
2.7. STRATEGIC ANALYSIS
2.7.1. INVESTMENT VS. ADOPTION MODEL
2.7.2. 360 DEGREE INDUSTRY ANALYSIS
2.7.3. PORTERS 5 FORCE MODEL
2.7.4. SEE-SAW ANALYSIS
2.7.5. CONSUMER ANALYSIS AND KEY BUYING CRITERIA
2.8. COMPETITIVE ANALYSIS
2.8.1. MARKET SHARE ANALYSIS
2.9. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
2.9.1. INVESTMENT OPPORTUNITIES BY REGIONS
2.9.2. OPPORTUNITIES IN EMERGING APPLICATIONS
2.9.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT
 
3. MARKET DETERMINANTS 
3.1. MARKET DRIVERS 
3.1.1. RISE IN DIAGNOSIS & TREATMENT OF CANCER
3.1.2. INCREASE GOVERNMENT FUNDING
3.1.3. GROWTH IN PERSONALIZED MEDICINE
3.1.4. TECHNICAL ADVANCES
3.2. MARKET RESTRAINTS 
3.2.1. LACK OF HEALTHCARE COVERAGE RESTRICTS THE ADOPTION
3.2.2. KNOWLEDGE CONSTRAINTS WITH RESPECT TO TECHNICAL KNOW-HOW
3.3. MARKET OPPORTUNITIES
3.3.1. GROWTH OF MARKET IN THE SUB-CONTINENT OF ASIA
3.3.2. WIDENING APPLICATIONS MARKET
3.4. MARKET CHALLENGES 
3.4.1. COMPLEXITY OF BIOLOGICAL SYSTEMS
3.4.2. UNCLEAR REGULATORY GUIDELINES
3.4.3. HIGH INSTRUMENTATION COSTS
 
4. MARKET SEGMENTATION 
4.1. GLOBAL BIOCHIPS MARKET BY TYPE 2014-2023 ($ MILLION)
4.1.1. MARKET DEFINITION AND SCOPE
4.1.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.1.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.1.4. OPPORTUNITY MATRIX
4.1.5. MARKET SEGMENTATION
4.1.5.1. DNA CHIPS 2014-2023 ($ MILLION)
4.1.5.1.1. MARKET APPLICATIONS
4.1.5.1.1.1. AGRICULTURAL BIOTECHNOLOGY
4.1.5.1.1.2. CANCER DIAGNOSIS AND TREATMENT
4.1.5.1.1.3. DRUG DISCOVERY
4.1.5.1.1.4. GENE EXPRESSION
4.1.5.1.1.5. GENOMICS
4.1.5.1.1.6. SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING
4.1.5.1.1.7. OTHERS
4.1.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.1.3. MARKET ESTIMATIONS AND FORECAST 2014-2023 ($ MILLION)
4.1.5.1.4. KEY PLAYERS & KEY PRODUCTS
4.1.5.1.5. KEY CONCLUSIONS
4.1.5.2. LAB-ON-A-CHIP 2014-2023 ($ MILLION)
4.1.5.2.1. MARKET APPLICATIONS
4.1.5.2.1.1. CLINICAL DIAGNOSTICS
4.1.5.2.1.2. DRUG DISCOVERY
4.1.5.2.1.3. GENOMICS
4.1.5.2.1.4. IN VITRO DIAGNOSIS (IVD) & POINT-OF-CARE (POC)
4.1.5.2.1.5. PROTEOMICS
4.1.5.2.1.6. OTHERS
4.1.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.2.3. MARKET ESTIMATIONS AND FORECAST 2014-2023 ($ MILLION)
4.1.5.2.4. KEY PLAYERS & KEY PRODUCTS
4.1.5.2.5. KEY CONCLUSIONS
4.1.5.3. PROTIEN CHIPS 2014-2023 ($ MILLION)
4.1.5.3.1. MARKET APPLICATIONS
4.1.5.3.1.1. DIAGNOSTICS
4.1.5.3.1.2. DRUG DISCOVERY
4.1.5.3.1.3. EXPRESSION PROFILING
4.1.5.3.1.4. HIGH THROUGHPUT SCREENING (HTS)
4.1.5.3.1.5. PROTEOMICS
4.1.5.3.1.6. OTHERS
4.1.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.3.3. MARKET ESTIMATIONS AND FORECAST 2014-2023 ($ MILLION)
4.1.5.3.4. KEY PLAYERS & KEY PRODUCTS
4.1.5.3.5. KEY CONCLUSIONS
4.1.5.4. OTHERS 2014-2023 ($ MILLION)
4.1.5.4.1. MARKET APPLICATIONS
4.1.5.4.1.1. CELL ARRAYS
4.1.5.4.1.2. TISSUE ARRAYS
4.1.5.4.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.4.3. MARKET ESTIMATIONS AND FORECAST 2014-2023 ($ MILLION)
4.1.5.4.4. KEY PLAYERS & KEY PRODUCTS
4.1.5.4.5. KEY CONCLUSIONS
4.2. GLOBAL BIOCHIPS MARKET BY END USER 2014-2023 ($ MILLION)
4.2.1. MARKET DEFINITION AND SCOPE
4.2.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.2.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.2.4. OPPORTUNITY MATRIX
4.2.5. MARKET SEGMENTATION
4.2.5.1. BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES 2014-2023 ($ MILLION)
4.2.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.1.2. MARKET ESTIMATIONS AND FORECAST 2014-2023 ($ MILLION)
4.2.5.1.3. KEY PLAYERS & KEY PRODUCTS
4.2.5.1.4. KEY CONCLUSIONS
4.2.5.2. HOSPITALS AND DIAGNOSTICS CENTERS 2014-2023 ($ MILLION) 
4.2.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.2.2. MARKET ESTIMATIONS AND FORECAST 2014-2023 ($ MILLION)
4.2.5.2.3. KEY PLAYERS & KEY PRODUCTS
4.2.5.2.4. KEY CONCLUSIONS
4.2.5.3. ACADEMIC & RESEARCH INSTITUTES 2014-2023 ($ MILLION)
4.2.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.3.2. MARKET ESTIMATIONS AND FORECAST 2014-2023 ($ MILLION)
4.2.5.3.3. KEY PLAYERS & KEY PRODUCTS
4.2.5.3.4. KEY CONCLUSIONS
 
5. COMPETITIVE LANDSCAPE
5.1. KEY STRATEGIES
5.1.1. LIST OF M&A 
5.1.2. LIST OF JV
5.1.3. LIST OF PRODUCT LAUNCHES
5.1.4. LIST OF PARTNERSHIP
 
6. GLOBAL BIOCHIPS MARKET BY REGION (REVENUE ANALYSIS) 2014-2023 ($ MILLION)
6.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
6.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
6.3. OPPORTUNITY MATRIX
6.4. GEOGRAPHIC SEGMENTATION
6.4.1. NORTH AMERICA
6.4.1.1. INDUSTRY APPLICATION ANALYSIS
6.4.1.2. TOP COUNTRY ANALYSIS
6.4.1.2.1. U.S. 
6.4.1.2.1.1. MARKET ESTIMATIONS AND FORECAST 2014-2023 ($ MILLION)
6.4.1.2.1.2. KEY PLAYERS & KEY PRODUCTS
6.4.1.2.1.3. KEY CONCLUSIONS
6.4.1.2.2. CANADA
6.4.1.2.2.1. MARKET ESTIMATIONS AND FORECAST 2014-2023 ($ MILLION)
6.4.1.2.2.2. KEY PLAYERS & KEY PRODUCTS
6.4.1.2.2.3. KEY CONCLUSIONS
6.4.2. EUROPE
6.4.2.1. INDUSTRY APPLICATION ANALYSIS
6.4.2.2. TOP COUNTRY ANALYSIS
6.4.2.2.1. UK
6.4.2.2.1.1. MARKET ESTIMATIONS AND FORECAST 2014-2023 ($ MILLION)
6.4.2.2.1.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.1.3. KEY CONCLUSIONS
6.4.2.2.2. FRANCE
6.4.2.2.2.1. MARKET ESTIMATIONS AND FORECAST 2014-2023 ($ MILLION)
6.4.2.2.2.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.2.3. KEY CONCLUSIONS
6.4.2.2.3. GERMANY
6.4.2.2.3.1. MARKET ESTIMATIONS AND FORECAST 2014-2023 ($ MILLION)
6.4.2.2.3.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.3.3. KEY CONCLUSIONS
6.4.2.2.4. SPAIN
6.4.2.2.4.1. MARKET ESTIMATIONS AND FORECAST 2014-2023 ($ MILLION)
6.4.2.2.4.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.4.3. KEY CONCLUSIONS
6.4.2.2.5. ITALY 
6.4.2.2.5.1. MARKET ESTIMATIONS AND FORECAST 2014-2023 ($ MILLION)
6.4.2.2.5.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.5.3. KEY CONCLUSIONS
6.4.2.2.6. REST OF EUROPE
6.4.2.2.6.1. MARKET ESTIMATIONS AND FORECAST 2014-2023 ($ MILLION)
6.4.2.2.6.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.6.3. KEY CONCLUSIONS
6.4.3. ASIA PACIFIC
6.4.3.1. INDUSTRY APPLICATION ANALYSIS
6.4.3.2. TOP COUNTRY ANALYSIS
6.4.3.2.1. CHINA
6.4.3.2.1.1. MARKET ESTIMATIONS AND FORECAST 2014-2023 ($ MILLION)
6.4.3.2.1.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.1.3. KEY CONCLUSIONS
6.4.3.2.2. INDIA
6.4.3.2.2.1. MARKET ESTIMATIONS AND FORECAST 2014-2023 ($ MILLION)
6.4.3.2.2.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.2.3. KEY CONCLUSIONS
6.4.3.2.3. JAPAN
6.4.3.2.3.1. MARKET ESTIMATIONS AND FORECAST 2014-2023 ($ MILLION)
6.4.3.2.3.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.3.3. KEY CONCLUSIONS
6.4.3.2.4. SOUTH KOREA
6.4.3.2.4.1. MARKET ESTIMATIONS AND FORECAST 2014-2023 ($ MILLION)
6.4.3.2.4.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.4.3. KEY CONCLUSIONS
6.4.3.2.5. AUSTRALIA
6.4.3.2.5.1. MARKET ESTIMATIONS AND FORECAST 2014-2023 ($ MILLION)
6.4.3.2.5.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.5.3. KEY CONCLUSIONS
6.4.3.2.6. REST OF ASIA PACIFIC
6.4.3.2.6.1. MARKET ESTIMATIONS AND FORECAST 2014-2023 ($ MILLION)
6.4.3.2.6.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.6.3. KEY CONCLUSIONS
6.4.4. ROW
6.4.4.1. INDUSTRY APPLICATION ANALYSIS
6.4.4.2. TOP COUNTRY ANALYSIS
6.4.4.2.1. LATIN AMERICA
6.4.4.2.1.1. MARKET ESTIMATIONS AND FORECAST 2014-2023 ($ MILLION)
6.4.4.2.1.2. KEY PLAYERS & KEY PRODUCTS
6.4.4.2.1.3. KEY CONCLUSIONS
6.4.4.2.2. MIDDLE EAST & AFRICA 
6.4.4.2.2.1. MARKET ESTIMATIONS AND FORECAST 2014-2023 ($ MILLION)
6.4.4.2.2.2. KEY PLAYERS & KEY PRODUCTS
6.4.4.2.2.3. KEY CONCLUSIONS
 
7. COMPANY PROFILES
7.1. AFFYMETRIX INC
7.1.1. OVERVIEW
7.1.2. PRODUCT PORTFOLIO
7.1.3. STRATEGIC INITIATIVES 
7.1.4. SCOT ANALYSIS
7.2. AGILENT TECHNOLOGIES INC
7.2.1. OVERVIEW
7.2.2. PRODUCT PORTFOLIO
7.2.3. STRATEGIC INITIATIVES 
7.2.4. SCOT ANALYSIS 
7.3. BIOCHAIN INSTITUTE INC
7.3.1. OVERVIEW
7.3.2. PRODUCT PORTFOLIO
7.3.3. STRATEGIC INITIATIVES 
7.3.4. SCOT ANALYSIS 
7.4. BIOMÉRIEUX SA
7.4.1. OVERVIEW
7.4.2. PRODUCT PORTFOLIO
7.4.3. STRATEGIC INITIATIVES 
7.4.4. SCOT ANALYSIS 
7.5. BIO-RAD LABORATORIES INC
7.5.1. OVERVIEW
7.5.2. PRODUCT PORTFOLIO
7.5.3. STRATEGIC INITIATIVES 
7.5.4. SCOT ANALYSIS 
7.6. CALIPER LIFE SCIENCES IN
7.6.1. OVERVIEW
7.6.2. PRODUCT PORTFOLIO
7.6.3. STRATEGIC INITIATIVES 
7.6.4. SCOT ANALYSIS 
7.7. CEPHEID INC
7.7.1. OVERVIEW
7.7.2. PRODUCT PORTFOLIO
7.7.3. STRATEGIC INITIATIVES 
7.7.4. SCOT ANALYSIS 
7.8. CYBRDI INC
7.8.1. OVERVIEW
7.8.2. PRODUCT PORTFOLIO
7.8.3. STRATEGIC INITIATIVES 
7.8.4. SCOT ANALYSIS 
7.9. EMD MILLIPORE
7.9.1. OVERVIEW
7.9.2. PRODUCT PORTFOLIO
7.9.3. STRATEGIC INITIATIVES 
7.9.4. SCOT ANALYSIS 
7.10. FLUIDIGM CORP
7.10.1. OVERVIEW
7.10.2. PRODUCT PORTFOLIO
7.10.3. STRATEGIC INITIATIVES 
7.10.4. SCOT ANALYSIS 
7.11. GAMIDA FOR LIFE GROUP
7.11.1. OVERVIEW
7.11.2. PRODUCT PORTFOLIO
7.11.3. STRATEGIC INITIATIVES 
7.11.4. SCOT ANALYSIS 
7.12. ILLUMINA INC
7.12.1. OVERVIEW
7.12.2. PRODUCT PORTFOLIO
7.12.3. STRATEGIC INITIATIVES 
7.12.4. SCOT ANALYSIS 
7.13. IMGENEX
7.13.1. OVERVIEW
7.13.2. PRODUCT PORTFOLIO
7.13.3. STRATEGIC INITIATIVES 
7.13.4. SCOT ANALYSIS 
7.14. LIFE TECHNOLOGIES CORP
7.14.1. OVERVIEW
7.14.2. PRODUCT PORTFOLIO
7.14.3. STRATEGIC INITIATIVES 
7.14.4. SCOT ANALYSIS
7.15. ORIGENE TECHNOLOGIES INC
7.15.1. OVERVIEW
7.15.2. PRODUCT PORTFOLIO
7.15.3. STRATEGIC INITIATIVES 
7.15.4. SCOT ANALYSIS 
7.16. SAMSUNG ELECTRONICS CO LTD
7.16.1. OVERVIEW
7.16.2. PRODUCT PORTFOLIO
7.16.3. STRATEGIC INITIATIVES 
7.16.4. SCOT ANALYSIS
7.17. MERCK PATENT GMBH
7.17.1. OVERVIEW
7.17.2. PRODUCT PORTFOLIO
7.17.3. STRATEGIC INITIATIVES 
7.17.4. SCOT ANALYSIS
 
LIST OF TABLES
1. GLOBAL BIOCHIPS MARKET BY TYPE 2014-2023 ($ MILLION)
2. GLOBAL DNA CHIPS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
3. GLOBAL LAB ON A CHIP MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
4. GLOBAL PROTIEN CHIPS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
5. GLOBAL OTHER CHIPS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
6. GLOBAL BIOCHIP MARKET BY END USER 2014-2023 ($ MILLION)
7. GLOBAL BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES BY GEOGRAPHY 2014-2023 ($ MILLION)
8. GLOBAL HOSPITALS AND DIAGNOSTICS CENTERS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
9. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
10. GLOBAL OTHERS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
11. NORTH AMERICA BIOCHIPS MARKET 2014-2023 ($ MILLION)
12. EUROPE BIOCHIPS MARKET 2014-2023 ($ MILLION)
13. ASIA PACIFIC BIOCHIPS MARKET 2014-2023 ($ MILLION)
14. REST OF THE WORLD BIOCHIPS MARKET 2014-2023 ($ MILLION)
 
LIST OF FIGURES
1. GLOBAL DNA CHIPS MARKET 2014-2023 ($ MILLION)
2. GLOBAL LAB ON A CHIP MARKET 2014-2023 ($ MILLION)
3. GLOBAL PROTIEN CHIPS MARKET 2014-2023 ($ MILLION)
4. GLOBAL OTHER CHIPS MARKET 2014-2023 ($ MILLION)
5. GLOBAL BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES MARKET 2014-2023 ($ MILLION)
6. GLOBAL HOSPITALS AND DIAGNOSTICS CENTERS MARKET 2014-2023 ($ MILLION)
7. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET 2014-2023 ($ MILLION)
8. UNITED STATES (U.S.) BIOCHIPS MARKET 2014-2023 ($ MILLION)
9. CANADA BIOCHIPS MARKET 2014-2023 ($ MILLION)
10. UNITED KINGDOM (UK) BIOCHIPS MARKET 2014-2023 ($ MILLION)
11. FRANCE BIOCHIPS MARKET 2014-2023 ($ MILLION)
12. GERMANY BIOCHIPS MARKET 2014-2023 ($ MILLION)
13. SPAIN BIOCHIPS MARKET 2014-2023 ($ MILLION)
14. ITALY BIOCHIPS MARKET 2014-2023 ($ MILLION)
15. ROE BIOCHIPS MARKET 2014-2023 ($ MILLION)
16. INDIA BIOCHIPS MARKET 2014-2023 ($ MILLION)
17. CHINA BIOCHIPS MARKET 2014-2023 ($ MILLION)
18. JAPAN BIOCHIPS MARKET 2014-2023 ($ MILLION)
19. KOREA BIOCHIPS MARKET 2014-2023 ($ MILLION)
20. AUSTRALIA BIOCHIPS MARKET 2014-2023 ($ MILLION)
21. ROAPAC BIOCHIPS MARKET 2014-2023 ($ MILLION)
22. LATIN AMERICA BIOCHIPS MARKET 2014-2023 ($ MILLION)
23. MENA BIOCHIPS MARKET 2014-2023 ($ MILLION)

FAQ

How can I purchase a report?
We offer an easy way to purchase any report of your choice from various domains that we offer. You can easily search for your desired reports by simply using the search bar on our website's home page. For multiple purchases, you can add reports to the shopping cart, fill a detail form and check out. We accept payments though authentic and trusted payment gateways which accept all major credit cards.
How safe is to use my credit card? Is my information secure?
We ensure complete safety to all online transactions made by credit cards. We use most secure encryption technology available today for the electronic transactions and all our credit card sales are secured with an SSL technology. Your information is highly secure and confidential.
Can I get a discount?
We send discount offers through email as per your request. In case you would like to receive discounts, please sign up for our newsletter.
I want to buy only a chapter. I don't need complete report.
Yes you can buy your desired chapter/page or the entire report, by just clicking on the table of contents in any report and selecting chapter of your interest. We do have separate pricing for chapters/reports/excel sheets/presentation pages etc.
Can I get reports on my desired topic specially which is not available in your current portfolio?
Do call us or mail us the topic of your preference. Our dedicated team on analysts will prepare a report as per your preference and requirements.
When do I get access to the report(s) that I have purchased?
We will email you your purchased report right after we receive your payment through any of the payment options.
Will I receive any invoice for my purchase?
Yes we will email you invoice/payment confirmation with the order details once we receive your payment.
In what format will the reports be available in?
All the reports will be available in PDF format for download.

Request for Sample
Select License Type
Required More Information

0731 4042636

+91 9713031393

NAVIGATION LINK

OUR SERVICES

credit card

CONNECT WITH US

Occams Business Research & Consulting Pvt. Ltd.

Landline: 0731 4042636 

Handheld: +91 9713031393

Email: [email protected]

 

 

  • facebook
  • twitter
  • blog
  • linkdin
  • google plus
  • youtube
Go To Top
viewthroughconversion